Saccadic Bradykinesia in Parkinson’s Disease: Preliminary Observations

Related Articles:

• Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
• Saccadic Bradykinesia in Parkinson's Disease: Preliminary Observations April 6, 2021 Mov Disord. 2021 Apr 6. doi: 10.1002/mds.28609. Online ahead of print.NO ABSTRACTPMID:33822392 | DOI:10.1002/mds.28609
• Saccadic Bradykinesia in Parkinson's Disease: Preliminary Observations April 6, 2021 Mov Disord. 2021 Apr 6. doi: 10.1002/mds.28609. Online ahead of print.NO ABSTRACTPMID:33822392 | DOI:10.1002/mds.28609
• Monthly Research Review – February 2021 February 28, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2021. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news…
• Monthly research review – March 2021 March 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during March 2021. The post is divided into ten parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD. August 24, 2019 Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD. Mov Disord. 2019 Aug 23;: Authors: Stuart S, Lawson RA, Yarnall AJ, Nell J, Alcock L, Duncan GW, Khoo TK, Barker RA, Rochester L, Burn DJ, ICICLE-PD study group Abstract BACKGROUND: Cumulative dementia incidence in Parkinson's disease (PD) is significant, with major personal and socioeconomic impacts on individuals with PD and their…
• 2021: Wish list January 26, 2021 # # # # Here at the Science of Parkinson’s, we don’t like making predictions – that’s a fool’s game. We would rather focus our attention on interesting ideas and trends, discussing what we hope to see happen in the future, and exploring different ways and means by which change could occur. It is done in the hope that someone…
• Monthly Research Review: Jaunary 2020 January 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2020. The post is divided into seven parts based on the type of research: Basic biology, Disease mechanism, Clinical research, New clinical trials, Clinical trial news, Other news, and…
• Forget Special K, maybe focus on LysoK February 20, 2021 # # # # Over the last 20 years, researchers have identified a number of genetic variations that can confer an increased risk of developing Parkinson’s. Tiny alterations in regions of DNA (called genes) – which provide the instructions for making a protein – can increase one’s chances of Parkinson’s. A better understanding of the biological pathways associated with these…
• Monthly Research Review – November 2020 November 30, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Inexpensive Hand-Tracker Accurately Measures Bradykinesia in Parkinson’s Patients, Small Study Suggests January 21, 2019 An inexpensive off-the-shelf hand-tracker can objectively and reliably measure Parkinson’s disease-related slowness of movement (bradykinesia) over time, both in a clinical setting or at a patient’s home, researchers report. The study, “Objective evaluation of bradykinesia in Parkinson’s disease using an inexpensive marker-less motion tracking system,” was published in Physiological Measurement. Accurately assessing bradykinesia, or the progressive slowness of movement over…
• Hypomania and saccadic changes in Parkinson's disease: influence of D2 and D3 dopaminergic signalling. January 17, 2021 Related ArticlesHypomania and saccadic changes in Parkinson's disease: influence of D2 and D3 dopaminergic signalling. NPJ Parkinsons Dis. 2020 Jan 17;6(1):5 Authors: Pelzer EA, Dillenburger B, Grundmann S, Iliaev V, Aschenberg S, Melzer C, Hess M, Fink GR, Eggers C, Tittgemeyer M, Timmermann L Abstract In order to understand the influence of two dopaminergic signalling pathways, TaqIA rs1800497 (influencing striatal…
• Monthly Research Review – August 2019 August 31, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during August 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• What TDO about KMO? March 5, 2021 # # # # New approaches for potentially slowing the progression of Parkinson’s are being announced on a regular basis. Some of them can not be independently replicated (such is the nature of science), while others open up whole new areas of research. Recently scientists have reported that inhibiting certain aspects of the kynurenine pathway – which plays a critical…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Being ly-mphatic about drainage issues February 4, 2021 # # # # The lymphatic network is an important part of our body’s defense system. It is made up of an enormous web of vessels and nodes which help to protect us from infection and disease. This network transports a colourless fluid (called lymph), which serves two primary functions: 1.) it contains infection-fighting white blood cells that help in…
• PKG Device Shown to Detect Abnormal Movements in Parkinson’s, Bradykinesia December 4, 2020 The Parkinson’s Personal KinetiGraph (PKG), a small motion sensor device that can be worn on the wrist like a watch in patients with Parkinson’s disease, can be used to detect abnormal movements, especially those associated with bradykinesia at the earlier stages of the disorder, an observational study has found. The study, “More Sensitive Identification for Bradykinesia Compared to Tremors in…
• Trying to LIMP-2 the lysosome February 8, 2021 # # # # Lysosomes are small bags of enzymes that are used to break down material inside of cells – digesting newly absorbed food or recycling old/used proteins and rubbish. Recently researchers have been discovering increasing evidence that points towards dysfunction in lysosomes as a key influential player in neurodegenerative conditions, like Parkinson’s. There are several Parkinson’s genetic risk…
• The value of a great MDS (Movement Disorder Specialist) June 30, 2018 I haven’t written anything lately as life has been pretty busy. I wouldn’t say it’s calmed down much but somewhat. I have had some ideas of what to write about but nothing that made me grab the iPad to blog it out. However, now I have something I want to write about; the incredible value of having and seeing a…
• The basket case February 10, 2021 # # # # One of the more interesting pieces of clinical trial news in 2020 was the publication of the results of a “basket study” for neurological conditions. This was a trial that involved a drug being tested on a selection of neurodegenerative conditions, rather than just one condition. Between December 2013 to May 2017, researchers recruited a total…